Neutrophil serine proteases: Potential key regulators of cell signalling during inflammation

Journal of Internal Medicine

Volumn 257, Issue 4, 2005, Pages 319-328

  Wiedow, O ^a   Meyer Hoffert, Ulf ^b,c  

^a UNIVERSITY OF KIEL   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cathepsin G; Cytokines; Elastase; Proteinase 3; Receptor; TNF

Indexed keywords

CATHEPSIN G; CYTOKINE; ELASTASE; MYELOBLASTIN; SERINE PROTEINASE;

CELL COMMUNICATION; CELL SECRETION; ENZYME ACTIVITY; INFLAMMATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 16244397365     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2005.01476.x     Document Type: Review

References (77)

1. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003; 5: 1317-27.
2. Wiedow O, Muhle K, Streit V, Kameyoshi Y. Human eosinophils lack human leukocyte elastase. Biochim Biophys Acta 1996; 1315: 185-7.
3. Brinkmann V, Reichard U, Goosmann C et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532-5.
4. Weinrauch Y, Drujan D. Shapiro SD, Weiss J, Zychlinsky A. Neutrophil elastase targets virulence factors of enterobacteria. Nature 2002; 417: 91-4.
5. Wiedow O, Wiese F, Christophers E. Lesional elastase activity in psoriasis. Diagnostic and prognostic significance. Arch Dermatol Res 1995; 287: 632-5.
6. Scuderi P. Suppression of human leukocyte tumor necrosis factor secretion by the serine protease inhibitor p-toluenesulfonyl-L-arginine methyl ester (TAME). J Immunol 1989; 143: 168-73.
7. Kim KU, Kwon OJ, Jue DM. Pro-tumour necrosis factor cleavage enzyme in macrophage membrane/particulate. Immunology 1993; 80: 134-9.
8. Wendel A. Biochemical pharmacology of inflammatory liver injury in mice. Methods Enzymol 1990; 186: 675-80.
9. Robache-Gallea S, Morand V, Bruneau JM et al. In vitro processing of human tumor necrosis factor-alpha. J Biol Chem 1995; 270: 23688-92.
10. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440.
11. Cacquevel M, Lebeurrier N, Cheenne S, Vivien D. Cytokines in neuroinflammation and Alzheimer's disease. Curr Drug Targets 2004; 5: 529-34.
12. Hazuda D, Webb RL, Simon P, Young P. Purification and characterization of human recombinant precursor interleukin 1 beta. J Biol Chem 1989; 264: 1689-93.
13. Black RA, Kronheim SR, Cantrell M et al. Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 1988; 263: 9437-42.
14. Alnemri ES, Livingston DJ, Nicholson DW et al. Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171.
15. Thornberry NA, Bull HG, Calaycay JR et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356: 768-74.
16. Singer II, Scott S, Chin J et al. The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J Exp Med 1995; 182: 1447-59.
17. Hazuda DJ, Lee JC, Young PR. The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J Biol Chem 1988; 263: 8473-9.
18. Bomford R, Abdulla E, Hughes-Jenkins C, Simpkin D, Schmidt J. Antibodies to interleukin-1 raised with synthetic peptides: identification of external sites and analysis of interleukin-1 synthesis in stimulated human peripheral blood monocytes. Immunology 1987; 62: 543-9.
19. Fantuzzi G, Ku G, Harding MW et al. Response to local inflammation of IL-1 beta-converting enzyme-deficient mice. J Immunol 1997; 158: 1818-24.
20. Sugawara S, Uehara A, Nochi T et al. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol 2001; 167: 6568-75.
21. Tsutsui H, Kayagaki N, Kuida K et al. Caspase-1-independent. Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 1999; 11: 359-67.
22. Takeda K, Tsutsui H, Yoshimoto T et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998; 8: 383-90.
23. Joosten LA, van De Loo FA, Lubberts E et al. An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J Immunol 2000; 165: 6553-8.
24. Siegmund B. Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammation. Biochem Pharmacol 2002; 64: 1-8.
25. Meyer-Hoffert U, Wingertszahn J, Wiedow O. Human leukocyte elastase induces keratinocyte proliferation by epidermal growth factor receptor activation. J Invest Dermatol 2004; 123: 338-45.
26. Rogalski C, Meyer-Hoffert U, Proksch E, Wiedow O. Human leukocyte elastase induces keratinocyte proliferation in vitro and in vivo. J Invest Dermatol 2002; 118: 49-54.
27. Meyer-Hoffert U, Rogalski C, Seifert S et al. Trypsin induces epidermal proliferation and inflammation in murine skin. Exp Dermatol 2004; 13: 234-41.
28. Wiedow O, Wiese F, Streit V, Kalm C, Christophers E. Lesional elastase activity in psoriasis, contact dermatitis, and atopic dermatitis. J Invest Dermatol 1992; 99: 306-9.
29. Kohri K, Ueki IF, Nadel JA. Neutrophil elastase induces mucin production by ligand-dependent epidermal growth factor receptor activation. Am J Physiol Lung Cell Mol Physiol 2002; 283: L531-40.
30. Nadel JA, Burgel PR. The role of epidermal growth factor in mucus production. Curr Opin Pharmacol 2001; 1: 254-8.
31. Voynow JA, Fischer BM, Malarkey DE et al. Neutrophil elastase induces mucus cell metaplasia in mouse lung. Am J Physiol lung Cell Mol Physiol 2004; 287: L1293-302.
32. Devaney JM, Greene CM, Taggart CC, Carroll TP, O'Neill SJ, McElvaney NG. Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4. FEBS Lett 2003; 544: 129-32.
33. Walsh DE, Greene CM, Carroll TP et al. Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88/IRAK/TRAF-6 in human bronchial epithelium. J Biol Chem 2001; 276: 35494-9.
34. Johnson GB, Brunn GJ, Platt JL. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol 2004; 172: 20-4.
35. 2-chloride system. Am J Pathol 1993; 143: 907-17.
36. Buczek-Thomas JA, Nugent MA. Elastase-mediated release of heparan sulfate proteoglycans from pulmonary fibroblast cultures. A mechanism for basic fibroblast growth factor (bFGF) release and attenuation of bfgf binding following elastase-induced injury. J Biol Chem 1999; 274: 25167-72.
37. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004; 84: 579-621.
38. Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin SR. Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 2000; 275: 6819-23.
39. Uehara A, Sugawara S, Muramoto K, Takada H. Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2. J Immunol 2002; 169: 4594-603.
40. Loew D, Perrault C, Morales M et al. Proteolysis of the exo-domain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Biochemistry 2000; 39: 10812-22.
41. Cumashi A, Ansuini H, Celli N et al. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets. Thromb Haemost 2001; 85: 533-8.
42. Ahn HS, Chackalamarmil S, Boykow G, Graziano MP, Foster C. Development of proteinase-activated receptor 1 antagonists as therapeutic agents for thrombosis, restenosis and inflammatory diseases. Curr Pharm Des 2003; 9: 2349-65.
43. Yang JJ, Preston GA, Pendergraft WF et al. Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. Am J Pathol 2001; 158: 581-92.
44. Preston GA, Zarella CS, Pendergraft WF III et al. Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38 MAPK signaling pathways. J Am Soc Nephrol 2002; 13: 2840-9.
45. Pendergraft WF III, Rudolph EH, Falk RJ et al. Proteinase 3 sidesteps caspases and cleaves p21(Waf1/Cip1/Sdi1) to induce endothelial cell apoptosis. Kidney Int 2004; 65: 75-84.
46. Bank U, Reinhold D, Schneemilch C, Kunz D, Synowitz HJ, Ansorge S. Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation. J Interferon Cytokine Res 1999; 19: 1277-87.
47. Porteu F, Brockhaus M, Wallach D, Engelmann H, Nathan CF. Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils. J Biol Chem 1991; 266: 18846-53.
48. Tralau T, Meyer-Hoffert U, Schroder JM, Wiedow O. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis. Exp Dermatol 2004; 13: 316-25.
49. Sadallah S, Hess C, Miot S, Spertini O, Lutz H, Schifferli JA. Elastase and metalloproteinase activities regulate soluble complement receptor 1 release. Eur J Immunol 1999; 29: 3754-61.
50. Beaufort N, Leduc D, Rousselle JC et al. Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin G. J Immunol 2004; 172: 540-9.
51. Hunter MG, Druhan LJ, Massullo PR, Avalos BR. Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor. Am J Hematol 2003; 74: 149-55.
52. Galon J, Moldovan I, Galinha A et al. Identification of the cleavage site involved in production of plasma soluble Fc gamma receptor type III (CD16). Eur J Immunol 1998; 28: 2101-7.
53. Le Barillec K, Si-Tahar M, Balloy V, Chignard M. Proteolysis of monocyte CD14 by human leukocyte elastase inhibits lipopolysaccharide-mediated cell activation. J Clin Invest 1999; 103: 1039-46.
54. Doring G, Frank F, Boudier C, Herbert S, Fleischer B, Bellon G. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. J Immunol 1995; 154: 4842-50.
55. Bank U, Kupper B, Reinhold D, Hoffmann T, Ansorge S. Evidence for a crucial role of neutrophil-derived serine proteases in the inactivation of interleukin-6 at sites of inflammation. FEBS Lett 1999; 461: 235-40.
56. van Kessel KP, van Strijp JA, Verhoef J. Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils. J Immunol 1991; 147: 3862-8.
57. Ariel A, Yavin EJ, Hershkoviz R et al. IL-2 induces T cell adherence to extracellular matrix: inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase. J Immunol 1998; 161: 2465-72.
58. Padrines M, Wolf M, Walz A, Baggiolini M. Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett 1994; 352: 231-5.
59. Nufer O, Corbett M, Walz A. Amino-terminal processing of chemokine ENA-78 regulates biological activity. Biochemistry 1999; 38: 636-42.
60. Champagne B, Tremblay P, Cantin A, St Pierre Y. Proteolytic cleavage of ICAM-1 by human neutrophil elastase. J Immunol 1998; 161: 6398-405.
61. Robledo O, Papaioannou A, Ochietti B et al. ICAM-1 isoforms: specific activity and sensitivity to cleavage by leukocyte elastase and cathepsin G. Eur J Immunol 2003; 33: 1351-60.
62. Hermant B, Bibert S, Concord E et al. Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration. J Biol Chem 2003; 278: 14002-12.
63. Zhu J, Nathan C, Jin W et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 2002; 111: 867-78.
64. Hyytiainen M, Taipale J, Heldin CH, Keski-Oja J. Recombinant latent transforming growth factor beta-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release. J Biol Chem 1998; 273: 20669-76.
65. Gibson TL, Cohen P. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases. Growth Horm IGF Res 1999; 9: 241-53.
66. Zaidi SH, You XM, Ciura S, Husain M, Rabinovitch M. Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 2002; 105: 516-21.
67. Cowan B, Baron O, Crack J, Coulber C, Wilson GJ, Rabinovitch M. Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits after heterotopic cardiac transplantation. J Clin Invest 1996; 97: 2452-68.
68. O'Blenes SB, Zaidi SH, Cheah AY, McIntyre B, Kaneda Y, Rabinovitch M. Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration. Circulation 2000; 102(Suppl. 3): III289-95.
69. Simpson AJ, Wallace WA, Marsden ME et al. Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection. J Immunol 2001; 167: 1778-86.
70. Inoue KI, Takano H, Shimada A et al. Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol Pharmacol 2004; 67: 673-80.
71. Zeiher BG, Artigas A, Vincent JL et al. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 2004; 32: 1695-702.
72. Zeiher BG, Matsuoka S, Kawabata K, Repine JE. Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics. Crit Care Med 2002; 30(Suppl.): S281-7.
73. Tamakuma S, Ogawa M, Aikawa N et al. Relationship between neutrophil elastase and acute lung injury in humans. Pulm Pharmacol Ther 2004; 17: 271-9.
74. Taooka Y, Maeda A, Hiyama K, Ishioka S, Yamakido M. Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 1997; 156: 260-5.
75. Honore S, Attalah HL, Azoulay E et al. Beneficial effect of an inhibitor of leukocyte elastase (EPI-hNE-4) in presence of repeated lung injuries. Shock 2004; 22: 131-6.
76. Grano V, Tasco G, Casadio R et al. Reduction of active elastase concentration by means of immobilized inhibitors: a novel therapeutic approach. Biotechnol Prog 2004; 20: 968-74.
77. Ferkol T, Cohn LA, Phillips TE, Smith A, Davis PB. Targeted delivery of antiprotease to the epithelial surface of human tracheal xenografts. Am J Respir Crit Care Med 2003; 167: 1374-9.